Caris MPI, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2008

Location

Irving TX US

Primary Industry

Biotechnology

About

Founded in 2008 and based in Texas, US, Caris MPI, Inc., dba Caris Life Sciences, operates as a biotechnology company that conducts molecular oncology research for drug development through machine learning genetic sequencing. The company's platform provides clinical trial solutions to accompany the firm's drug development research.

Current Investors

OrbiMed Advisors, T Rowe Price, NexPoint Asset Management

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Bioinformatics, Healthcare IT, Oncology/Cancer Treatment, Pharmaceutical Research & Development, Medical Software

Website

www.carislifesciences.com

Verticals

Artificial Intelligence, HealthTech

Company Stage

Mature - Growth Capital

Total Amount Raised

Subscriber access only

Key Contacts

Name	Position	Start Date	End Date	Vcard	Bio
	Advisory Board Member						BM
	Board Member						BM
	Chairman Of The Board Of Directors						BM

BM Board Member

Name	Firm	Deal Date	Number Of Deals	Vcard
						AI LP
						AI LP

AI Active Investor LP Lead Provider

Want to see more?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.